Best in Biotech 29 Apr 2025 Six biotech companies leading the charge in hemophilia treatment Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi therapies. April 29, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 28 Apr 2025 U.S. budget cuts: what is the impact on therapeutic research? We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs and lawsuits. April 28, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Whitepapers 28 Apr 2025Function-focused single-cell analysis to accelerate antibody discovery Discover how early functional screening at the single-cell level transforms therapeutic development of your antibodies. April 28, 2025 Share WhatsApp Twitter Linkedin Email
In Depth 25 Apr 2025 The past, present, and future of genome sequencing Genome sequencing is the process of determining the complete DNA sequence of an organism’s genome, a step-by-step decoding of all the genetic instructions. In humans, that means reading around 3 billion base pairs to reveal everything from disease risk and drug response to ancestry and evolution. For many years, genome sequencing was largely limited to […] April 25, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 25 Apr 2025AI in biotech today, and how it will impact the industry tomorrow AI is driving innovation across industries, including biotech, but where is its influence felt most and what opportunities for future impact are emerging? April 25, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Best in Biotech 24 Apr 2025 21 UK biotech companies you should know about Take a closer look at 21 of the top UK biotech companies, as the nation’s biotech scene is now one of the most vibrant in Europe. April 24, 2025 - 27 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 23 Apr 2025 The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in on FDA approval. April 23, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Expert Advice 22 Apr 2025 Tariffs and trade war: A guide for expanding biotech business internationally Find out how you can mitigate the risks on your way to make your biotech company global amidst the tariffs and trade mayhem. April 22, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Apr 2025 Seven biotechs to watch in the hepatitis B space Here we take a look at seven biotechs with clinical drug candidates on a quest to win regulatory approval to treat HBV. April 22, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 17 Apr 2025 Biomaterials in construction: meet the startups reinventing our buildings We will explore the various biomaterials making a mark in the construction field and how biotechs could potentially transform a carbon-intensive industry. April 17, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Apr 2025 HIV innovation: Six companies developing new treatments in 2025 Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure. April 16, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 16 Apr 2025 Beyond CRISPR: Brink Therapeutics raises $4 million with engineered recombinases Learn about Brink Tx as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy. April 16, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email